TIMOTHY TYSON

CIK 1207405 · CEO and President · last filed 2024-06-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13

Companies

3

Total Filings

27

Lifetime Open-Market Net

$101.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SYRS Director 33,189 $0.00 $13 $106.0K 5 2024-06-07
TYME TECHNOLOGIES, INC. (TYME) Delisted Director 0 $0.31 $0 $0 8 2022-09-16
VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted CEO and President 118,496 -$4.9K 2 2007-11-01

Recent Filings · Page 2 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-11-16 Grant (A) $0
2018-08-28 TYME TECHNOLOGIES, INC. (TYME) Delisted Grant (A) $0 EDGAR
2018-08-15 Grant (A) $0
2018-07-17 Grant (A) $0
2018-05-29 TYME TECHNOLOGIES, INC. (TYME) Delisted Grant (A) $0 EDGAR
2018-04-06 Grant (A) $0
2018-01-02 Mixed +21,428 $7.9K
2017-11-27 TYME TECHNOLOGIES, INC. (TYME) Delisted Grant (A) $0 EDGAR
2017-08-16 Exer (M) +3,658 $0
2017-07-18 Grant (A) $0
Showing 1120 of 27
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.